The enhanced Th17 response hastened CKD and interstitial fibrosis and was inhibited by angiotensin II type-1 receptor (AT1R) antagonist, Losartan (Mehrotra et al., 2015). The gene discussed is AGTR1; the disease is chronic kidney disease.